EVAR失败后晚期开放转换的系统综述与荟萃分析
系统检索截至2018年6月的文献,纳入27项回顾性研究共791例患者,比较择期与紧急晚期开放转换的30天死亡率。择期转换30天死亡率为2.8%,紧急转换为28.1%,后者约高10倍,但文献方法学质量普遍较差。
要点
- 择期晚期开放转换30天死亡率为2.8%,紧急转换为28.1%。
- I型内漏和破裂分别是择期和紧急转换最常见指征。
- 择期转换30天死亡率与初次择期开放腹主动脉瘤修复接近。
核心结论
- 紧急晚期开放转换的30天死亡率约为择期转换的10倍。
- 择期晚期开放转换的30天死亡率与初次择期开放腹主动脉瘤修复接近。
- I型内漏和破裂分别是择期和紧急转换最常见的指征。
研究设计与样本
- 系统综述与荟萃分析,检索截至2018年6月的电子数据库。
- 纳入27项回顾性研究,共791例患者,其中择期转换617例、紧急转换174例。
- 纳入标准为EVAR后>30天的晚期开放转换并报告30天死亡率。
- 采用随机效应模型合并30天死亡率,方法学质量用MINORS评估。
主要发现
- 从初次EVAR到转换的平均时间为35.1个月(95%CI 30.4-39.8个月)。
- 经腹膜途径占平均74.0%(95%CI 70.9%-77.0%),完全移除内移植物占60.4%(95%CI 57.0%-63.8%)。
- 并发症发生率为36.7%(95%CI 27.0%-46.4%),转换后需临时或永久血液透析者占3.9%(95%CI 2.6%-5.2%)。
- 择期晚期转换30天死亡率合并估计为2.8%(95%CI 1.5%-4.0%;P = .726)。
- 紧急晚期转换30天死亡率合并估计为28.1%(95%CI 18.9%-37.3%;P < .001)。
临床怎么用
- 对EVAR后需晚期开放转换者,应区分择期与紧急情形评估手术风险。
- 紧急转换30天死亡率高,提示需优化紧急转换的围手术期管理。
- 择期转换风险接近初次择期开放修复,可用于术前咨询参考。
局限性
- 纳入研究均为回顾性研究,方法学质量多数较差(中位MINORS评分6,四分位距5-7)。
- 部分内移植物类型未报告(12.3%),可能影响结果解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In this study, we systematically reviewed late open conversions after failed endovascular aneurysm repair (EVAR), assessed the methodologic quality of the included studies, and performed a meta-analysis on the 30-day mortality rates for urgent and elective late conversions. METHODS: Electronic databases were systematically searched for studies published up to June 2018 that focused on late open conversion of failed EVAR (ie, >30 days after the initial EVAR), reported the primary outcome of 30-day mortality rate, and distinguished the 30-day mortality rate between urgent and elective late conversions. Two independent reviewers assessed the methodologic quality of the included studies with the Methodological Index for Non-Randomized Studies. Data on baseline demographics, indication for conversion, surgical approach, and early and late mortality rates were recorded. Reported data correspond to the average or range of the means reported in the individual studies. A random-effects model was used to pool 30-day mortality rates for urgent and elective late conversion. RESULTS: There were 27 retrospective studies with a total of 791 patients available for analysis, with 617 elective and 174 urgent late conversions. The methodologic quality was mostly poor (median, 6; interquartile range, 5-7). The mean time from primary EVAR to conversion was 35.1 months (95% confidence interval [CI], 30.4-39.8 months). The most commonly explanted endografts were Excluder (W. L. Gore & Associates, Flagstaff, Ariz) in 16.2%, Talent (Medtronic, Minneapolis, Minn) in 14.5%, and AneuRx (Medtronic) in 13.7%. Nineteen other types of endografts were used in 43.3%; the type of endograft was not reported in 12.3%. A transperitoneal approach was used in a mean 74.0% of conversions (95% CI, 70.9%-77.0%), and complete endograft explantation was performed in 478 (60.4%) patients (95% CI, 57.0%-63.8%). The complication rate was 36.7% (95% CI, 27.0%-46.4%). Temporary or permanent hemodialysis after conversion was required in 3.9% of patients (95% CI, 2.6%-5.2%). The pooled estimate for the 30-day mortality rate was 2.8% (95% CI, 1.5%-4.0%; P = .726) for elective late conversions and 28.1% (95% CI, 18.9%-37.3%; P < .001) for urgent late conversions. CONCLUSIONS: Type I endoleak and rupture are the most common indications for, respectively, elective and urgent conversions. A 10 times higher 30-day mortality rate was observed for patients treated with late open conversion in an urgent vs elective setting. The 30-day mortality rate of elective late open conversions is almost comparable to that of primary elective open abdominal aortic aneurysm repair procedures. For the interpretation of the outcomes of the review, however, the methodologic quality of the available literature should be considered.
引用
- Goudeketting SR, Fung Kon Jin PHP, Ünlü Ç, et al. Systematic review and meta-analysis of elective and urgent late open conversion after failed endovascular aneurysm repair. J Vasc Surg. 2019. PMID: 30956006. doi:10.1016/j.jvs.2018.11.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。